Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21507715

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2011 May
First author
Moreau P

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2011 Jun;12(6):522
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2011 May;12(5):410-1. doi: 10.1016/S1470-2045(11)70098-5.
    note
    Source null
    related pmid
    21507716
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2011 Jun 14;8(7):385. doi: 10.1038/nrclinonc.2011.89.
    note
    Source null
    related pmid
    21670749
    relationship
    Comment in

Authors and identifiers

  1. name
    Moreau P
    type
    Author
  2. name
    Pylypenko H
    type
    Author
  3. name
    Grosicki S
    type
    Author
  4. name
    Karamanesht I
    type
    Author
  5. name
    Leleu X
    type
    Author
  6. name
    Grishunina M
    type
    Author
  7. name
    Rekhtman G
    type
    Author
  8. name
    Masliak Z
    type
    Author
  9. name
    Robak T
    type
    Author
  10. name
    Shubina A
    type
    Author
  11. name
    Arnulf B
    type
    Author
  12. name
    Kropff M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Moreau P
    type
    Author
  2. name
    Pylypenko H
    type
    Author
  3. name
    Grosicki S
    type
    Author
  4. name
    Karamanesht I
    type
    Author
  5. name
    Leleu X
    type
    Author
  6. name
    Grishunina M
    type
    Author
  7. name
    Rekhtman G
    type
    Author
  8. name
    Masliak Z
    type
    Author
  9. name
    Robak T
    type
    Author
  10. name
    Shubina A
    type
    Author
  11. name
    Arnulf B
    type
    Author
  12. name
    Kropff M
    type
    Author
bibliography ids
  1. nci-bib-70ccdbf3072c9488c1541775
book metadata
content sha256
567064ff6c748c0a63c64e8d6e05b71f4a2aabc01a82c42a06cdb2de33f6ff90
document type
citation
dois
  1. 10.1016/S1470-2045(11)70081-X
electronic publication date
display
2011 Apr 18
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21507715
immutable id
pubmed:21507715@567064ff6c748c0a63c64e8d6e05b71f4a2aabc01a82c42a06cdb2de33f6ff90
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
5
name
The Lancet. Oncology
nlm unique id
100957246
pages
431-40
volume
12
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2011 Jun;12(6):522
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2011 May;12(5):410-1. doi: 10.1016/S1470-2045(11)70098-5.
    note
    Source null
    related pmid
    21507716
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2011 Jun 14;8(7):385. doi: 10.1038/nrclinonc.2011.89.
    note
    Source null
    related pmid
    21670749
    relationship
    Comment in
outcomes validated
false
pmid
21507715
provenance
batch id
a366a1bc8ed89d8d7ca5
provider
NCBI PubMed ESummary
record sha256
2cdc4c65ed86e709fcee9ce424be7bd9cf59ff36e563509c8baac549a6c12f69
response sha256
c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
retrieved at
2026-09-09T23:46:40.540025+00:00
publication date
display
2011 May
precision
month
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21507715/
title
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.

Preserved source evidence · Not medical advice